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Long-term Follow-up of Retained Functionless Pacing Leads
YUJI NAKAZATO, YASURO NAKATA*, GAKU SEKITA, HARUYO YAMASHITA, YASUNOBU KAWANO,
KAORU NAKAZATO, MASAYUKI YASUDA, MASATAKA SUMIYOSHI
From Division of Cardiology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo
and Juntendo Izu-Nagaoka Hospital*, Shizuoka, Japan
NAKAZATO ET AL.: Long-term Follow-up of Retained Functionless Pacing Leads. To investigate the clinical
outcome of retained functionless leads, we retrospectively studied patients with one or more abandoned pacing
leads over the period from 1987 to 1999. We identified 28 patients with abandoned leads (15 males and 13 females
with an average age of 70) out of 720 total patients. The number of retained leads was 1 in 23 patients, 2 in 4
patients, and 3 in 1 patient. The mean follow-up period after lead retention was 64.5 months (range 3-216 months).
The reasons for retention were as follows: lead fracture (17), infection (4), lead entrapment (3), threshold rise (2),
and mode change (2). The residual sites of leads were in the right atrium (12), the right ventricle (18), the tricuspid
valve (2), and the coronary sinus (1). During the follow-up period, 26 patients had no adverse complications requiring
lead extraction. Only 2 patients had an infection with septicemia, and one of them underwent surgical removal of the
infected lead. Anti-coagulation treatment was administered in 11 patients (39%), but symptomatic venous thrombosis
or pulmonary thromboembolism were not recognized clinically in any patients. We concluded that the incidence of
adverse complications for abandoned pacing leads is very low. Most retained leads are safe in the long-term and do
not require extraction unless an infection is present. (J HK Coll Cardiol 2001;9:139-143)
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Introduction

Results

If functionless pacing leads are abandoned and
retained in the heart, they can potentially cause venous
thrombosis or additional infection.1-7 However, it is still
questionable whether all abandoned leads should be
extracted or not, despite the improvements in lead
extraction techniques.8-10 The purpose of this study is to
investigate the long-term clinical outcome of pacing
leads abandoned for various reasons.

Number of abandoned leads and total implanted
leads

Patients and Methods

The distribution of abandoned leads and total
implanted leads for these 28 patients are shown in Figure
1. One lead was abandoned in 23 patients, 2 leads in 4
patients and 3 leads in 1 patient. In respect to the total
number of implanted leads, two leads were implanted
in 13 patients, 3 leads in 11 patients, 4 leads in 3 patients
and 5 leads in 1 patient.

Retained site of abandoned leads

We performed a retrospective study from 1987
to 1999, and we found 28 patients with abandoned leads
out of 720 patients. They were 15 males and 13 females
with the average age of 70. Mean follow-up period was
64.5 months ranging from 3 to 216 months. Anticoagulation medications were given in 11 patients
(39%). One patient received warfarin post mitral valve
replacement. Three cases were treated with ticlopidine
due to a history of cerebrovascular accidents, and the
remaining 7 patients were given only aspirin. These
medications were not given for the prevention of venous
thrombosis itself. Patient characteristics are described
on Table 1. We investigated the clinical outcome of
retained leads and the incidence of adverse
complications.

Figure 2 shows the sites of the abandoned leads.
Eighteen leads were abandoned in the right ventricle,
13 leads in the right atrium, 2 leads in the tricuspid valve,
and 1 lead in the coronary sinus.
Table 1. Clinical characterisitics of patients with
retained leads
Number of patients
Male / female
Age (years)
Follow-up period (months)
Anti-coagulation
Warfarin
Ticlopidine
Aspirin

28
15 / 23
70±9.9 (range 47-87)
64.5 (range 3-216)
11 (39%)
1
3
7

Figure 1. The number of abandoned leads and total implanted leads.
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Figure 2. The retained site of abandoned leads.

Discussion

Reasons for retention
Reasons for abandonment are indicated in Figure
3. The primary reason was lead fracture, which was seen
in 17 patients (61%). Infection was the cause of lead
abandonment in 4 patients (14%). Other causes were
lead entrapment in 3 patients (2 in tricuspid valve and 1
in the right atrium), threshold rise in 2 patients, and the
change of pacing mode in 2 patients.

Adverse complications
Clinical results of complications are shown in
Figure 4. During the follow-up period, 2 patients had
lead infection with septicemia. One patient had 2
implanted leads and required surgical removal of the
entire infected lead system. The other patient had 3 leads,
1 abandoned ventricular lead and 2 functional atrial and
ventricular leads, but was successfully treated by
medical therapy.
In the remaining 26 patients, none had
symptomatic venous thrombosis including pulmonary
thromboembolism independent of anticoagulation
medication.
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Amazing recent advances in lead extraction
techniques and technology have led to attempts to
remove many functionless pacing leads.9-11 Driving these
advances has been the concept that if abandoned leads
were left in the heart, they would have the potential to
cause thromboembolism or additional infection. 1-7
However, lead extraction has always presented
potentially critical adverse complications such as cardiac
perforation or massive bleeding.11 Moreover, several
studies have revealed that abandoned leads do not
necessarily need to be extracted unless infection is
present. 12-14 Therefore, the long-term outcomes of
retained leads are still controversial.8
Suga et al13 found in a study of 1,207 leads that
611 were functionless and 531 had been abandoned.
Since pacemaker-related complications were seen in
only 24 patients (5.5%), they concluded that the adverse
outcome of abandoned pacing leads is small. However,
they emphasized that patients with a large number of
abandoned leads should be carefully observed because
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Figure 3. The reasons for retention.

Figure 4. Clinical outcome of adverse complications.
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of the greater possibility of adverse complications.
DeCock et al14 also reported that the presence of multiple
(≥3) non-infected leads was not associated with
thromboembolic events during a follow-up period of
7.4±2.2 years. No differences were found between the
control and study groups with or without anticoagulation medication.
In the present study, we found 28 patients with
abandoned leads. While the cause of abandonment
varied, lead fracture was the most common reason. For
these 28 cases, most leads were retained unless infection
was present. Nevertheless, multiple leads in the heart
always give rise to the constant fear of thromboembolism.1-3
Anticoagulation is sometimes recommended for
preventing pulmonary thrombosis; however, no case was
found with obvious venous thrombosis or pulmonary
thromboembolism in this study. Asymptomatic thrombosis
could not be sufficiently evaluated, but even in patients
who had been confirmed for ipsilateral subclavian vein
occlusion, symptomatic venous complications were not
observed because of the development of collateral
circulation. Only 2 patients suffer from general infection
with septicemia. One of them required removal of the
entire lead system by surgery. Although the other patient
was able to be treated only with medication, abandoned
lead removal via surgical therapy is recommended if
infection is present. In conclusion, the incidence of
adverse complications for abandoned pacing leads is
very low, and most abandoned leads are safe over the
long-term and do not always need to be extracted unless
an infection is present.

J HK Coll Cardiol, Vol 9

References
1. Theiss W, Wirtzfeld A. Pulmonary embolisation of retained
transvenous pacemaker electrode. Br Heart J 1997;39:326-9.
2. Parry G, Goudevenos J, Jameson S, et al. Complication associated
with retained pacemaker leads. PACE 1991;14:1251-7.
3. Toumbouras M, Spanos P, Konstantaras C, et al. Inferior vena
cava thrombosis due to migration of retained functionless
pacemaker electrode. Chest 1982;82:785-6.
4. Bluhm G, Julander I, Levander-Lindgren M, et al. Septicemia
and endocarditis-uncommon but serious complications in
connection with permanent cardiac pacing. Scand J Thorac
Cardiovasc Surg 1982;16:65-70.
5. Rettig G, Doenecke P, Sen S, et al. Complications with retained
transvenous pacemaker electrodes. Am Heart J 1979;98:58794.
6. Choo MH, Holmes DR Jr, Gersh BJ, et al. Permanent pacemaker
infections: characterization and management. Am J Cardiol 1981;
48;559-64.
7. DeLeon SY, Bojar R, Koster NK, et al. Recurrent sepsis from
retained endocardial electrode in children: successful removal
with cardiopulmonary bypass. PACE 1984;7:166-8.
8. Hayes DL. Extraction of permanent pacing leads: there are still
controversies. Heart 1996;75:539-41.
9. Epstein LM, Byrd CL, Wilkoff BL, et al. Initial experience with
larger laser sheaths for the removal of transvenous pacemaker
and implantable defibrillator leads. Circulation 1999;100:51625.
10. Friedman RA, Zandt HV, Collins E, et al. Lead extraction in
young patients with and without congenital heart disease using
the subclavian approach. PACE 1996;19:778-83.
11. Byrd CL, Wilkoff BL, Love CJ, et al. Intravascular extraction
of problematic or infected permanent pacemaker leads: 19941996. PACE 1999;22:1348-57.
12. Furman S, Behrens M, Andrews C, et al. Retained pacemaker
leads. J Thorac Cardiovasc Surg 1987;94:770-2.
13. Suga C, Hayes DL, Hyberger LK, et al. Is there an adverse
outcome from abandoned pacing leads? J Interv Card
Electrophysiol 2000;4:493-9.
14. DeCock DE, Vinkers M, Van Campe LC, et al. Long-term
outcome of patients with multiple (3) noninfected transvenous
leads: a clinical and echocardiographic study. PACE 2000;23:
423-6.

July 2001

143

